RenovoRx, Inc. financial data

Symbol
RNXT on Nasdaq
Location
Mountain View, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 677% %
Debt-to-equity 35% % -60%
Return On Equity -122% % 50%
Return On Assets -91% % 30%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 36,649,916 shares 53%
Common Stock, Shares, Outstanding 36,649,916 shares 53%
Entity Public Float $26,600,000 USD 72%
Common Stock, Value, Issued $4,000 USD 100%
Weighted Average Number of Shares Outstanding, Basic 36,646,278 shares 47%
Weighted Average Number of Shares Outstanding, Diluted 36,646,278 shares 47%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $266,000 USD
Cost of Revenue $53,000 USD
Research and Development Expense $6,329,000 USD 21%
General and Administrative Expense $4,891,000 USD -20%
Operating Income (Loss) $11,620,000 USD -15%
Nonoperating Income (Expense) $515,000 USD -46%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $11,105,000 USD -21%
Earnings Per Share, Basic 0 USD/shares 33%
Earnings Per Share, Diluted 0 USD/shares 33%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $10,044,000 USD 5%
Accounts Receivable, after Allowance for Credit Loss, Current $169,000 USD
Inventory, Net $272,000 USD
Other Assets, Current $145,000 USD
Assets, Current $10,980,000 USD
Property, Plant and Equipment, Net $13,000 USD
Operating Lease, Right-of-Use Asset $213,000 USD
Assets $11,206,000 USD 12%
Accounts Payable, Current $869,000 USD 27%
Accrued Liabilities, Current $1,015,000 USD -6.5%
Liabilities, Current $1,884,000 USD 6.3%
Operating Lease, Liability, Noncurrent $134,000 USD
Liabilities $3,128,000 USD 5.7%
Retained Earnings (Accumulated Deficit) $58,446,000 USD -23%
Stockholders' Equity Attributable to Parent $8,078,000 USD 14%
Liabilities and Equity $11,206,000 USD 12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,381,000 USD -53%
Net Cash Provided by (Used in) Financing Activities $10,811,000 USD 99%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 36,649,916 shares 53%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $7,428,000 USD 131%
Interest Paid, Excluding Capitalized Interest, Operating Activities $5,000 USD
Deferred Tax Assets, Valuation Allowance $16,784,000 USD 32%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0 pure
Deferred Tax Assets, Gross $16,863,000 USD 32%
Operating Lease, Liability $236,000 USD
Depreciation $1,000 USD
Payments to Acquire Property, Plant, and Equipment $2,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $2,389,000 USD -2.7%
Lessee, Operating Lease, Liability, to be Paid $258,000 USD
Property, Plant and Equipment, Gross $15,000 USD
Operating Lease, Liability, Current $102,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two $111,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $118,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $22,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $111,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $11,035,000 USD 24%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15,000,000 shares 0%
Unrecognized Tax Benefits $827,000 USD 28%
Additional Paid in Capital $54,410,000 USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $79,000 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%